This is a high profile event organised in association with Bloomberg L.P. and attended by an executive level audience of over 450 investors, pharmas, fund managers and capital raising companies.

The 2004 Programme:
Featuring up to 40 presentations by early to mid-stage biotech companies as well as IPO prospects and small listed companies, this event will include a series of panels, roundtable discussions and keynote presentations from leading investment, pharmaceutical and biotech companies.

Aiming to provide an expert outlook on growth and investment activity in Europe’s biotech industry, our leading investment, pharmaceutical and biotech companies will host a number of specialist panels on Investment Trends, Bio Partnering Trends in, In and Out Licensing, Global Development, Corporate Funding through Capital Markets, Asset Allocation into Life Sciences, Bio Generics and Creative Deal Making.

This specially designed event means that attendance at this year’s Biotech in Europe Investor Forum guarantees, timely and topical discussions and a highly effective means of networking with industry counterparts and decision makers from throughout this sector.

PRE-CONFERENCE WORKSHOP
In addition to the main conference we are holding a pre-conference workshop on Monday 04 October, 2pm to 5pm entitled:
Connecting with the US: Strategies and Lessons for Establishing a Presence in the US Market

For full details of the workshop and how to register, please click here.

Confirmed Speakers to date include:
Brian Hargreaves, Global Sector Head, Healthcare, 3i Group
Tim McCarthy, CFO, Alizyme
Dr. Chris Henderson, Director Global Licensing, AstraZeneca
Joël Besse, Senior Partner, Atlas Venture
Dr. rer. nat. Markus Metzger, Senior Analyst Biotech, Bank Vontobel AG
Dr. Tilman Dumrese, Biotech Analyst, Bank Vontobel AG
Hoda Abou-Jamra, Founder & CEO, BioExec Ventures
Morris Berrie, CEO, Biotechnology Investment Today
Dr. Jonathan D. Turner, Head of Corporate Department, Pharmaceutical Licensing, Boehringer Ingelheim
Susan Flynn, Partner, Coller Capital
Spiro Rombotis, CEO, Cyclacel
Dimitri Dimitriou, Chief Executive Officer, DyoDelta Biosciences
Sandrine Cailleteau, Head of Corporate Business Development & Licensing, Laboratories Fournier S.A.
Marc Perret, Director, Gilde Investment Management
Dr. Peter Reinisch, Partner, Global Life Science Ventures
Dr. Andreas Wicki, CEO, HBM BioVentures
Seth Yakatan, Partner, Katan Associates
Stan Yakatan, Chairman, Katan Associates
Dr. Andrew Barber, Global L & BD Leader, High Potential, Corporate Business Development, Merck KGaA
Adi Seffer, Partner, Morgan Lewis
Anthony Warnock-Smith, Partner, Morgan Lewis
Dr Christian Zschocke, Managing Partner, Morgan Lewis
Otello Stampacchia PhD, Consultant
Martin Friedman, Head of Pharma M&A, Novartis Pharma
Dennis Purcell, Senior Managing Director, Perseus-Soros BioPharmaceutical Fund, LP
Hans van Swaay, Head of Private Equity, Pictet & Cie
Dr. Frank Grams, Global Alliance Director, Roche
Jonathan Freeman, Director, Strategy & Portfolio Evaluation Corporate Business Development, Serono International
Antoine Papiernik, Managing Partner, Sofinnova
Marc Zahn, Vice President, Head of Marketing and Sales, SWX Swiss Exchange
Dr. Alexandra Goll, General Partner, Techno Venture Management
Nick Lowcock, Managing Director, Warburg Pincus
William van Eesteren, Director, Wilshire Associates Europe

Workshops:
In addition to our series of panel discussions and keynote presentations this Forum will once again include our highly popular ‘Sector Workshops’. Featuring over 40 presentations from biotechnology companies looking to raise finance and partner, our workshops will provide investors and pharmas an excellent opportunity to review an exciting range of emerging life science companies.

Sponsorship:
Sachs Associates, in association with Bloomberg L.P has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase your position your company in this market.

Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.

To learn more about sponsorship & presenting opportunities, please contact Hannah-Louise Cook.
on + 44 20 7405 5544 or email.

Summary & Registration:
If you'd like to download a summary pdf and registration form, please click here, alternatively to register online click here.
back to top